Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment

Fig. 5

Overview of the evidence base for beta-blockers versus control in cardiovascular health.a Compared to other medications. b In trials with a low risk of bias. c In contemporary trials with majority undergoing reperfusion. AF, atrial fibrillation; CAD, coronary artery disease; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; MI, myocardial infarction; RR, risk ratio

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us